In a patient with chronic hemorrhoids and lifelong constipation, can lateral internal sphincterotomy prevent future straining and recurrence of hemorrhoids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lateral Internal Sphincterotomy Does NOT Prevent Hemorrhoid Recurrence and May Worsen Outcomes

Lateral internal sphincterotomy (LIS) should NOT be performed as an adjunct to hemorrhoidectomy or as a preventive measure for hemorrhoid recurrence in patients with chronic constipation and hemorrhoids. Randomized studies have definitively shown that adding LIS to hemorrhoid surgery does not improve outcomes and actually increases the incidence of fecal incontinence 1.

Why LIS Is Contraindicated for Hemorrhoid Prevention

Evidence Against LIS as Hemorrhoid Adjunct

  • Randomized controlled trials have explicitly demonstrated that lateral internal sphincterotomy provides no benefit when added to hemorrhoid excision 1.

  • Instead of helping, LIS increases postoperative incontinence rates when combined with hemorrhoidectomy, creating a composite sphincter injury from both the hemorrhoidectomy-related trauma and the sphincterotomy itself 1, 2.

  • Hemorrhoidectomy alone already carries up to 12% risk of sphincter defects documented by ultrasonography and anal manometry, caused by excessive retraction and dilation during the procedure 1, 2.

The Mechanism Problem

  • LIS treats anal fissures by reducing internal sphincter hypertonia—a pathophysiology completely unrelated to hemorrhoid formation 3, 4.

  • Hemorrhoids develop from vascular engorgement, straining, and increased intra-abdominal pressure, not from sphincter spasm 5.

  • Cutting the internal anal sphincter does nothing to address the venous congestion, prolapse, or bleeding that characterize hemorrhoidal disease 1, 5.

The Correct Approach: Treating the Root Cause

Address Constipation Directly

The actual solution for preventing hemorrhoid recurrence in a patient with lifelong constipation is aggressive management of the underlying bowel dysfunction, not sphincter surgery 5, 4.

  • Increase dietary fiber to 25-30 grams daily using bulk-forming agents like psyllium husk (5-6 teaspoons with 600 mL water daily) to produce soft, bulky stools that pass without straining 5.

  • Ensure adequate fluid intake to soften stool and reduce the need for straining during defecation 5.

  • Avoid prolonged sitting on the toilet and straining, which are the primary mechanical factors that cause hemorrhoid formation and recurrence 5.

Pharmacologic Adjuncts

  • Oral flavonoids (phlebotonics) can reduce bleeding, pain, and swelling, though 80% of patients experience symptom recurrence within 3-6 months after stopping 5.

  • Osmotic laxatives such as polyethylene glycol or lactulose can be used safely for chronic constipation management 5.

Surgical Management When Needed

  • If hemorrhoidectomy is required for grade III-IV hemorrhoids, perform conventional excisional hemorrhoidectomy (Ferguson or Milligan-Morgan technique) WITHOUT adding LIS, which achieves 90-98% success rates with 2-10% recurrence 1, 5.

  • For persistent grade I-III internal hemorrhoids after conservative management fails, rubber band ligation is the first procedural intervention, with success rates of 70.5-89% and no sphincter injury risk 5.

Critical Pitfalls to Avoid

  • Never perform anal dilatation as an adjunct to hemorrhoid surgery—it causes sphincter injuries and results in 52% incontinence rate at 17-year follow-up 1, 5.

  • Do not attribute all anorectal symptoms to hemorrhoids—anal fissures occur in up to 20% of patients with hemorrhoids and require different treatment 5.

  • Recognize that LIS is indicated ONLY for chronic anal fissure (>8 weeks duration) that has failed 8 weeks of conservative topical therapy, not for hemorrhoid prevention 6, 4.

Long-Term Incontinence Risk of LIS

  • Even when LIS is performed for its correct indication (chronic anal fissure), 45% of patients experience some degree of fecal incontinence at some point postoperatively, with women affected more than men (53.4% vs 33.3%) 7.

  • Although most incontinence is transient, at long-term follow-up (mean >5 years), 6% still report flatus incontinence, 8% have minor soiling, and 1% experience loss of solid stool 7.

  • In the context of hemorrhoid surgery, where LIS provides no benefit, exposing the patient to these incontinence risks is unjustifiable 1, 7.

The Bottom Line

The patient's lifelong constipation—not sphincter hypertonia—is driving hemorrhoid formation and recurrence. Performing LIS would subject him to permanent sphincter division and incontinence risk without addressing the actual problem 1, 7. Focus instead on aggressive fiber supplementation, adequate hydration, avoidance of straining, and appropriate hemorrhoid-specific interventions (rubber band ligation or hemorrhoidectomy when indicated) to prevent recurrence 5, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Risk of Sphincter Defects and Incontinence with Hemorrhoidectomy and Lateral Internal Sphincterotomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Hemorrhoids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Lateral Internal Sphincterotomy: Impact on Anal Sexual Function vs Continence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is a lateral internal sphincterotomy?
In a patient with chronic anal fissure previously treated with lateral internal sphincterotomy, hemorrhoidectomy and fissurectomy three years ago (complicated by constipation) and a low trans‑sphincteric fistulotomy involving less than 30 % of the external sphincter performed seven months ago with revision, now experiencing persistent deep‑pelvic sexual arousal loss and reduced urinary awareness, what is the most likely diagnosis and the appropriate first‑line management?
In a 38‑year‑old man who underwent a lateral internal anal sphincterotomy (with hemorrhoidectomy, fissurectomy and low trans‑sphincteric fistulotomy) and now reports loss of deep‑pelvic “anchor” sensation and blunted urinary sensation, how much resting internal anal sphincter pressure is typically lost, and does this loss represent loss of passive IAS tone rather than a guarding contraction?
What are the likely causes and recommended management for loss of deep pelvic sensation affecting sexual arousal and urinary perception in a 38‑year‑old man after lateral internal sphincterotomy, hemorrhoidectomy, fissurectomy, and low trans‑sphincteric fistulotomy with normal pudendal nerve testing?
Was it appropriate to perform a fissureectomy, lateral sphincterotomy, and internal hemorrhoidectomy on a patient with a anal fissure caused by pushing too hard during diarrhea, who had temporary relief with sitz baths, and also had grade 3 hemorrhoids with bleeding?
How can I differentiate septic arthritis from gouty arthritis in a swollen second finger of the hand?
What is the maximum safe dose of lidocaine (with and without epinephrine) for local infiltration in a wound?
What is the recommended first‑line therapy, dosing, and monitoring for a middle‑aged adult with pemphigus vulgaris?
What is the recommended screening and management strategy for non‑alcoholic fatty liver disease in adult patients with human immunodeficiency virus infection?
In a patient with rheumatoid arthritis‑associated interstitial lung disease, restrictive pulmonary function pattern, rheumatoid factor 90 IU/mL and C‑reactive protein 5.6 mg/L, can hydroxychloroquine be used as sole therapy?
Are blurry vision, left‑sided abdominal sharp pain, and sudden acid reflux on cycle day 22 (8 days post‑ovulation after embryo transfer) typical implantation symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.